Short Interest in GT Biopharma, Inc. (NASDAQ:GTBP) Rises By 53.5%

GT Biopharma, Inc. (NASDAQ:GTBP – Free Report) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 204,600 shares, an increase of 53.5% from the May 31st total of 133,300 shares. Currently, 0.6% of the company’s stock are short sold. Based on an average […]

Related Keywords

,Nasdaq ,Renaissance Technologies ,Gt Biopharma Company Profile ,Baskin Financial Services Inc ,Atria Wealth Solutions Inc ,Wells Fargo Company ,Gt Biopharma Inc ,Ef Hutton Acquisition Co ,Free Report ,Wealth Solutions ,Street Group ,Baskin Financial Services ,Tri Specific Killer Engager ,Gt Biopharma ,Nasdaq Gtbp ,Gtbp ,Medical ,Stocks ,Options ,Put ,Call ,